Colonic NeoplasiaNCT01181739
Computed Tomography (CT) Colonography Versus Optical Colonoscopy
An observational study of Colonic Neoplasia, run by University of British Columbia at 2 sites in Canada.
Trial summary
This study is designed to compare traditional Colonoscopy with CT Colonography, commonly known as "virtual colonoscopy". The study will compare the ability of both procedures as screening tests to identify polyps in the colon in patients at average risk for developing polyps. Read more about this study
- Who is it for?
- Ages 19 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Colonic Neoplasia
- How many people
- 100 participants
- Where
- 2 sitesCanada
- Study dates
- Oct 2008to Dec 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients 19 - 65 years of age at with a recognized indication for optical colonoscopy, including those high risk for colorectal cancer.
Who may be able to join
- 19 - 65 years of age
- Have a recognized indication for optical colonoscopy, including high risk for colorectal cancer
- Over 45 years of age with a family history of colorectal cancer, those with positive screening tests (FOBT, DRE, flexible sigmoidoscopy and contrast enema)
- Previous history of advanced adenomas and those with suggestive symptoms and signs (bleeding, abdominal pain, anemia)
- Must be able to read and understand English and must be able to give informed consent
Who cannot join
None listed.
Trial locations and contacts
2 sites in 1 country.
Michelle Jones contact
Canada2 sites, 2 recruiting
- Recruiting
St. Paul's Hospital
Vancouver, British Columbia, V6Z 1Y6
Michelle Jones, (604) 688-6332 ext. 237, michjon@telus.net
- Recruiting
Pacific Research Institute
Vancouver, British Columbia
Michelle Jones, (604) 688-6332 ext. 237, michjon@telus.net
About this study
Official title: The Effect of Experience and Training on the Accuracy of CT (Computed Tomography) Colonography in Comparison With Optical Colonoscopy in the Detection of Colonic Neoplasia
This study is designed to compare traditional Colonoscopy with CT Colonography, commonly known as "virtual colonoscopy". The study will compare the ability of both procedures as screening tests to identify polyps in the colon in patients at average risk for developing polyps. The patient preferences for each procedure will be assessed by means of a standardized questionnaire. As well the ability observers with differing levels of experience to read the CT scans and detect polyps will be compared. All patients will receive both CT scans and traditional colonoscopy on the same day.
Read the detailed description
- Purpose To study the Effect of Experience and Training on the Accuracy of CT (Computed Tomography) Colonography in Comparison with Optical Colonoscopy in the Detection of Colonic Neoplasia
- Hypotheses
- The accuracy (sensitivity and specificity) of interpretation of the CTC images will improve with each 100 scans examined. Less time will be required to interpret the CTC images after each successive 100 scans. The accuracy of each of the observers will be similar.
- The sensitivity and specificity will be similar for CTC and OC for the last 100 patients undergoing both examinations.
- Patients will prefer CTC to OC based on comfort and ease of the procedure.
- CTC will have the added benefit of identifying extra-colonic findings which will not be found on OC. CTC will be performed at a lower cost per patient with a lower complication rate than for OC and will take a similar amount of time to perform.
- Justification Screening is believed to decrease the incidences of colorectal cancer and death as a result of the detection of both precancerous lesions and cancers at early stages4-6. Fecal occult blood testing and flexible sigmoidoscopy can miss a substantial number of significant lesions7. Despite its risk, inconvenience, and cost, optical colonoscopy is the primary screening tool for colorectal cancer when performed every 10 years, beginning at 50 years of age in people who are at average risk8,9. Screening is also recommended at a younger age for populations at increased risk10.
Virtual colonoscopy is a rapidly evolving technique in which data from computed tomography (CT) is used to generate both two-dimensional and three-dimensional displays of the colon and rectum. This minimally invasive method for the examination of the colon, also referred to as CT colonography (CTC), is a promising alternative to optical colonoscopy for use in widespread screening, as it requires no intravenous administration of sedatives or analgesia and little recovery time.
Many studies have sought to compare the utility of CTC and optical colonoscopy (OC) in the detection of colonic polyps and adenocarcinomas in various patient populations.
Before CTC can be used in usual practice the training required by those interpreting the studies needs to be further studied so that guidelines can be created defining requirements necessary prior to implementation of this screening strategy.
- Study Objectives: To determine the effects of previous training and experience on the accuracy of polyp and cancer detection for CTC in patients at above average risk for colorectal cancer.
- To assess the learning curve of GI radiologists (experienced and not experienced with CTC interpretation), a GI fellow and a family physician as they acquire experience in reading CTC datasets by measuring the detection rates, miss rates and the amount of time needed to read images for the 1st, 2nd and 3rd set of 100 CTC's which they interpret.
- The study will also determine the sensitivity and specificity of CTC compared with OC for the detection of colonic polyps (of various sizes) and adenocarcinoma in patients at high risk for colorectal cancer (those over 45 years of age with a family history of colorectal cancer, those with positive screening tests and those with suggestive symptoms).
- Patient satisfaction with both CTC and OC will be evaluated by means of a patient questionnaire.
- The two procedures will be compared in terms of complication rates, the time required to perform each test, extra-colonic findings and the cost to perform each procedure per patient.
- Research Method A non-randomized, evaluator blinded study of 300 consecutive patients at high risk for colonic neoplasia referred for colonoscopy. Each patient is to undergo standard colonoscopy preparation on the day prior to CT Colonography (CTC) followed within 2 hours by optical colonoscopy (OC). Patients will be men and women aged 19 - 65 years who were scheduled to undergo elective colonoscopy referred from a suburban primary care setting.
Study population The study participants will consist of two main populations. The first will include patients at average to high risk of colonic neoplasia who are eligible for screening colonoscopy. Average risk patients are those aged 45-65 who wish to undergo screening for colorectal cancer. High risk patients include those with a family history of colorectal cancer, previous colorectal cancer or neoplasia, positive screening tests (Fecal Occult Blood (FOBT), flexible sigmoidoscopy, digital rectal exam or air contrast barium enema) and patients with gastrointestinal symptoms and signs (abdominal pain, rectal bleeding, anemia). Patients will be recruited from a suburban primary care medical clinic in Coquitlam, B.C. (North Road Medical Centre) and referred to a gastroenterology clinic in downtown Vancouver (Pacific Gastroenterology Associates) or recruited from the gastroenterology clinic directly.
Ethical approval will be obtained from the University of British Columbia and the St. Paul's Hospital Institutional Review Boards. A study investigator will obtain informed consent from potential study participants.
Design After obtaining informed consent, participants will be instructed to consume a clear liquid diet for the 24 hours prior to the exam. Patients will receive detailed instructions regarding bowel preparation using oral Picosalax and Bisacodyl suppositories to be taken on the day prior to their procedures (see Appendix 2). Instructions will also be provided regarding the intake of oral barium and gastrograffin which will be used as stool tagging agents (see Appendix 2). As both CTC and OC will take place on the same day, the preparation will be identical for both procedures. No sedative agents will be administered during CTC. Colonic distention for CTC will be achieved with automated low-pressure delivery of carbon dioxide. Patients will be allowed sips of clear fluid on the morning of the examinations and will then be kept without oral intake until after both CTC and OC are completed.
CT Colonography Patients will be given an appointment time for presentation to St. Paul's Hospital radiology department. After reporting, they will be asked to change into a hospital gown and CT scanning will be performed. Images will be acquired using the GE Lightspeed 64 row multidetector CT scanner. Slices will be obtained at 0.75mm resolution and will be reconstructed using GE Healthcare software at a resolution of 1.25mm. Scans will be obtained during a single breath hold using a low radiation exposure protocol (~30-50 mAs which corresponds to an absorbed radiation dose of 3-5 mSv). The quality and adequacy of the images will be assessed before patients leave the radiology department to await colonoscopy which will be performed within 2 hours.
Interpretation There will be 2 radiologist readers both experienced in gastrointestinal imaging and one of whom is experienced in CTC interpretation. The Radiologists will review the scans and record their findings in 4 separate envelopes, one for each section of the colon (rectum and sigmoid, descending, transverse and right colon). The size of lesions found will be recorded from the optimum view using electronic callipers. Finally, the radiologists will review the films for any extra-colonic findings that will be recorded separately. Similarly, a GI Fellow and a Family Physician will review the scans recording their findings in the same manner. However, at least one Radiologist will review the films at the time of the examination to ensure that they are of adequate quality and to provide their interpretation prior to OC. The amount of time taken to read the films for each reviewer will be recorded as a total time to read all views for each patient. Observers will be made aware of optical colonoscopy results after each 100 procedures.
Optical Colonoscopy Within 2 hours of finishing the CTC imaging, participants will undergo OC with conscious sedation using a combination of midazolam and Demerol or fentanyl to achieve patient comfort. An experienced gastroenterologist using an Olympus colonoscope will perform the colonoscopies. The endoscopist, blinded to the CTC results will examine the colon on withdrawal of the endoscope, recording findings for each of the four segments of the colon. Each segment is then to be sequentially unblinded allowing the endoscopist to review the Radiologists findings for each colonic segment on CTC. Polyps detected at endoscopy will be removed using standard techniques (biopsy forceps or snare cautery) and submitted for pathological assessment.
Advanced neoplasms will be divided by pathology into adenocarcinomas and polyps. Polyps will be further categorized according to size (≤5mm, 6-9mm and ≥10mm). Morphologic characteristics of the lesions will also be recorded by viewers as sessile, pedunculated or flat. Lesion size is to be determined by measurement of removed lesions (before fixation) or estimated at endoscopy by comparison to the biopsy forceps, for those lesions that are not removed.
Patient Questionnaires Following endoscopy, patients will be transferred to recovery area where they will undergo monitoring of their vital signs following standard practice guidelines, until they are ready for discharge. Immediately prior to discharge, patients will be given a 10 question written survey, for self-completion (see appendix 1). The recovery room nurse will give this to them after final consultation with the Gastroenterologist while in the recovery room. Patients will be given as much time as necessary to complete the survey and instruction to seal the survey in an envelope and return it to the nurse prior to leaving the recovery room.
In order to assess the test/retest reliability of the survey, a random sample of patients will be mailed a second survey (identical to the first) 3 - 4 weeks after the day of examination. Enclosed will be instructions for self-completion of the survey and a self addressed, postage paid, return envelope to allow for its return.
- Statistical Analysis The reference standard of polyp detection will be the results of OC after each colonic segment is re-examined once the CTC results are known. Tests of accuracy will be sensitivity, specificity, true positive and true negative results with comparison to the reference standard. ROC curves for CTC and OC will be derived after all tests are completed. The AUC for each tests' ROC curve will be used to compare accuracy between these two tests. ROC curves and the AUC statistic will be derived from the dataset once divided according to each 100 CTC performed and by each reader to evaluate the learning curve of this test. Tests of significance will be McNemar's test, paired t-tests, and chi-square tests as appropriate. Interobserver reliability will be reported as a kappa statistic.
- Conditions
- Colonic Neoplasia
- Keywords
- Colonoscopy, Virtual Colonoscopy, Colonography, Colorectal Cancer, Colonic Polyps, Screening
- Medical subject headings
- Colorectal Neoplasms, Colonic Polyps
What is being measured
The primary outcome is the main question the study is designed to answer.
CT colonography
CT colonography (CTC), is a promising alternative to optical colonoscopy for use in widespread screening, as it requires no intravenous administration of sedatives or analgesia and little recovery time.
Measured: During procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Aug 2010 (estimated)
- Study startOct 2008
- Primary completionDec 2013 (estimated)
- Study completionDec 2013 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Colonic NeoplasiaStudies of the same condition, open and under way.
- More trials run by University of British ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Collaborators
- Canadian Society of Intestinal Research
- Responsible party
- Sponsor
- Investigators
- Robert Enns, Dr., Principal investigator, University of British ColumbiaJacquie Brown, Dr., Study director, University of British ColumbiaJennifer Telford, Dr., Study director, University of British ColumbiaGregory Rosenfeld, Dr., Study director, University of British ColumbiaPari Tiwari, Dr., Study director, University of British ColumbiaDarin Krygier, Dr., Study director, University of British ColumbiaBrian Bressler, Dr., Study director, University of British ColumbiaPatrick Vos, Dr., Study director, University of British Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01181739
- Sponsor's protocol ID
- H08-00776
- Status last verified
- Apr 2013
- First submitted
- 11 Aug 2010
- Last updated
- 11 Apr 2013
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Apr 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Experience and Training on the Accuracy of CT (Computed Tomography) Colonography in Comparison With Optical Colonoscopy in the Detection of Colonic Neoplasia
- ClinicalTrials.gov ID
- NCT01181739
- Acronym / sponsor ID
- H08-00776
- Conditions
- Colonic Neoplasia
- Keywords
- Colonoscopy, Virtual Colonoscopy, Colonography, Colorectal Cancer, Colonic Polyps, Screening
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- University of British ColumbiaUniversity, hospital or other
- Collaborators
- Canadian Society of Intestinal Research
- Study start
- Oct 2008
- Primary completion
- Dec 2013 (estimated)
- Study completion
- Dec 2013 (estimated)
- First posted
- 13 Aug 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is designed to compare traditional Colonoscopy with CT Colonography, commonly known as "virtual colonoscopy". The study will compare the ability of both procedures as screening tests to identify polyps in the colon in patients at average risk for developing polyps. The patient preferences for each procedure will be assessed by means of a standardized questionnaire. As well the ability observers with differing levels of experience to read the CT scans and detect polyps will be compared. All patients will receive both CT scans and traditional colonoscopy on the same day.
Detailed description
- Purpose To study the Effect of Experience and Training on the Accuracy of CT (Computed Tomography) Colonography in Comparison with Optical Colonoscopy in the Detection of Colonic Neoplasia
- Hypotheses
- The accuracy (sensitivity and specificity) of interpretation of the CTC images will improve with each 100 scans examined. Less time will be required to interpret the CTC images after each successive 100 scans. The accuracy of each of the observers will be similar.
- The sensitivity and specificity will be similar for CTC and OC for the last 100 patients undergoing both examinations.
- Patients will prefer CTC to OC based on comfort and ease of the procedure.
- CTC will have the added benefit of identifying extra-colonic findings which will not be found on OC. CTC will be performed at a lower cost per patient with a lower complication rate than for OC and will take a similar amount of time to perform.
- Justification Screening is believed to decrease the incidences of colorectal cancer and death as a result of the detection of both precancerous lesions and cancers at early stages4-6. Fecal occult blood testing and flexible sigmoidoscopy can miss a substantial number of significant lesions7. Despite its risk, inconvenience, and cost, optical colonoscopy is the primary screening tool for colorectal cancer when performed every 10 years, beginning at 50 years of age in people who are at average risk8,9. Screening is also recommended at a younger age for populations at increased risk10.
Virtual colonoscopy is a rapidly evolving technique in which data from computed tomography (CT) is used to generate both two-dimensional and three-dimensional displays of the colon and rectum. This minimally invasive method for the examination of the colon, also referred to as CT colonography (CTC), is a promising alternative to optical colonoscopy for use in widespread screening, as it requires no intravenous administration of sedatives or analgesia and little recovery time.
Many studies have sought to compare the utility of CTC and optical colonoscopy (OC) in the detection of colonic polyps and adenocarcinomas in various patient populations.
Before CTC can be used in usual practice the training required by those interpreting the studies needs to be further studied so that guidelines can be created defining requirements necessary prior to implementation of this screening strategy.
- Study Objectives: To determine the effects of previous training and experience on the accuracy of polyp and cancer detection for CTC in patients at above average risk for colorectal cancer.
- To assess the learning curve of GI radiologists (experienced and not experienced with CTC interpretation), a GI fellow and a family physician as they acquire experience in reading CTC datasets by measuring the detection rates, miss rates and the amount of time needed to read images for the 1st, 2nd and 3rd set of 100 CTC's which they interpret.
- The study will also determine the sensitivity and specificity of CTC compared with OC for the detection of colonic polyps (of various sizes) and adenocarcinoma in patients at high risk for colorectal cancer (those over 45 years of age with a family history of colorectal cancer, those with positive screening tests and those with suggestive symptoms).
- Patient satisfaction with both CTC and OC will be evaluated by means of a patient questionnaire.
- The two procedures will be compared in terms of complication rates, the time required to perform each test, extra-colonic findings and the cost to perform each procedure per patient.
- Research Method A non-randomized, evaluator blinded study of 300 consecutive patients at high risk for colonic neoplasia referred for colonoscopy. Each patient is to undergo standard colonoscopy preparation on the day prior to CT Colonography (CTC) followed within 2 hours by optical colonoscopy (OC). Patients will be men and women aged 19 - 65 years who were scheduled to undergo elective colonoscopy referred from a suburban primary care setting.
Study population The study participants will consist of two main populations. The first will include patients at average to high risk of colonic neoplasia who are eligible for screening colonoscopy. Average risk patients are those aged 45-65 who wish to undergo screening for colorectal cancer. High risk patients include those with a family history of colorectal cancer, previous colorectal cancer or neoplasia, positive screening tests (Fecal Occult Blood (FOBT), flexible sigmoidoscopy, digital rectal exam or air contrast barium enema) and patients with gastrointestinal symptoms and signs (abdominal pain, rectal bleeding, anemia). Patients will be recruited from a suburban primary care medical clinic in Coquitlam, B.C. (North Road Medical Centre) and referred to a gastroenterology clinic in downtown Vancouver (Pacific Gastroenterology Associates) or recruited from the gastroenterology clinic directly.
Ethical approval will be obtained from the University of British Columbia and the St. Paul's Hospital Institutional Review Boards. A study investigator will obtain informed consent from potential study participants.
Design After obtaining informed consent, participants will be instructed to consume a clear liquid diet for the 24 hours prior to the exam. Patients will receive detailed instructions regarding bowel preparation using oral Picosalax and Bisacodyl suppositories to be taken on the day prior to their procedures (see Appendix 2). Instructions will also be provided regarding the intake of oral barium and gastrograffin which will be used as stool tagging agents (see Appendix 2). As both CTC and OC will take place on the same day, the preparation will be identical for both procedures. No sedative agents will be administered during CTC. Colonic distention for CTC will be achieved with automated low-pressure delivery of carbon dioxide. Patients will be allowed sips of clear fluid on the morning of the examinations and will then be kept without oral intake until after both CTC and OC are completed.
CT Colonography Patients will be given an appointment time for presentation to St. Paul's Hospital radiology department. After reporting, they will be asked to change into a hospital gown and CT scanning will be performed. Images will be acquired using the GE Lightspeed 64 row multidetector CT scanner. Slices will be obtained at 0.75mm resolution and will be reconstructed using GE Healthcare software at a resolution of 1.25mm. Scans will be obtained during a single breath hold using a low radiation exposure protocol (~30-50 mAs which corresponds to an absorbed radiation dose of 3-5 mSv). The quality and adequacy of the images will be assessed before patients leave the radiology department to await colonoscopy which will be performed within 2 hours.
Interpretation There will be 2 radiologist readers both experienced in gastrointestinal imaging and one of whom is experienced in CTC interpretation. The Radiologists will review the scans and record their findings in 4 separate envelopes, one for each section of the colon (rectum and sigmoid, descending, transverse and right colon). The size of lesions found will be recorded from the optimum view using electronic callipers. Finally, the radiologists will review the films for any extra-colonic findings that will be recorded separately. Similarly, a GI Fellow and a Family Physician will review the scans recording their findings in the same manner. However, at least one Radiologist will review the films at the time of the examination to ensure that they are of adequate quality and to provide their interpretation prior to OC. The amount of time taken to read the films for each reviewer will be recorded as a total time to read all views for each patient. Observers will be made aware of optical colonoscopy results after each 100 procedures.
Optical Colonoscopy Within 2 hours of finishing the CTC imaging, participants will undergo OC with conscious sedation using a combination of midazolam and Demerol or fentanyl to achieve patient comfort. An experienced gastroenterologist using an Olympus colonoscope will perform the colonoscopies. The endoscopist, blinded to the CTC results will examine the colon on withdrawal of the endoscope, recording findings for each of the four segments of the colon. Each segment is then to be sequentially unblinded allowing the endoscopist to review the Radiologists findings for each colonic segment on CTC. Polyps detected at endoscopy will be removed using standard techniques (biopsy forceps or snare cautery) and submitted for pathological assessment.
Advanced neoplasms will be divided by pathology into adenocarcinomas and polyps. Polyps will be further categorized according to size (≤5mm, 6-9mm and ≥10mm). Morphologic characteristics of the lesions will also be recorded by viewers as sessile, pedunculated or flat. Lesion size is to be determined by measurement of removed lesions (before fixation) or estimated at endoscopy by comparison to the biopsy forceps, for those lesions that are not removed.
Patient Questionnaires Following endoscopy, patients will be transferred to recovery area where they will undergo monitoring of their vital signs following standard practice guidelines, until they are ready for discharge. Immediately prior to discharge, patients will be given a 10 question written survey, for self-completion (see appendix 1). The recovery room nurse will give this to them after final consultation with the Gastroenterologist while in the recovery room. Patients will be given as much time as necessary to complete the survey and instruction to seal the survey in an envelope and return it to the nurse prior to leaving the recovery room.
In order to assess the test/retest reliability of the survey, a random sample of patients will be mailed a second survey (identical to the first) 3 - 4 weeks after the day of examination. Enclosed will be instructions for self-completion of the survey and a self addressed, postage paid, return envelope to allow for its return.
- Statistical Analysis The reference standard of polyp detection will be the results of OC after each colonic segment is re-examined once the CTC results are known. Tests of accuracy will be sensitivity, specificity, true positive and true negative results with comparison to the reference standard. ROC curves for CTC and OC will be derived after all tests are completed. The AUC for each tests' ROC curve will be used to compare accuracy between these two tests. ROC curves and the AUC statistic will be derived from the dataset once divided according to each 100 CTC performed and by each reader to evaluate the learning curve of this test. Tests of significance will be McNemar's test, paired t-tests, and chi-square tests as appropriate. Interobserver reliability will be reported as a kappa statistic.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 19 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients 19 - 65 years of age at with a recognized indication for optical colonoscopy, including those high risk for colorectal cancer.
Key inclusion criteria (5 listed)
- 19 - 65 years of age
- Have a recognized indication for optical colonoscopy, including high risk for colorectal cancer
- Over 45 years of age with a family history of colorectal cancer, those with positive screening tests (FOBT, DRE, flexible sigmoidoscopy and contrast enema)
- Previous history of advanced adenomas and those with suggestive symptoms and signs (bleeding, abdominal pain, anemia)
- Must be able to read and understand English and must be able to give informed consent
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
CT colonography
Time frame: During procedure
CT colonography (CTC), is a promising alternative to optical colonoscopy for use in widespread screening, as it requires no intravenous administration of sedatives or analgesia and little recovery time.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Apr 2013.
Related trials for Colonic Neoplasia
Recruiting
MRD Monitoring in Colorectal Cancer Using ctDNA
Colorectal Neoplasms, Colorectal Cancer (Diagnosis)
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Ampulla of Vater Carcinoma, Appendix Carcinoma
Not yet recruitingPhase 2/3
Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLC
Cachexia; Cancer, Cachexia
Active, not recruitingPhase 3
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Colon Adenocarcinoma, DNA Repair Disorder
RecruitingObservational study
Avera Cancer Sequencing and Analytics Protocol (ASAP)
Cancer, Cancer Diagnosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michelle Jones contact
Robert Enns, Dr. principal investigator
University of British Columbia
Jacquie Brown, Dr. study director
University of British Columbia
Jennifer Telford, Dr. study director
University of British Columbia
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colonic Neoplasia, run by University of British Columbia at 2 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 11 Apr 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Michelle Jones ((604) 688-6332 ext. 237), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
CT colonography (time frame: During procedure). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2013.